A novel TLR4 accessory molecule drives hepatic oncogenesis through tumor-associated macrophages

Doyeon Kim1, Carter A Allen2, Dongjun Chung2

  • 1Pelotonia Institute for Immune-Oncology, The Ohio State University Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, 410 W 12th Ave, Columbus, OH, 43210, USA; Division of Medical Oncology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, 410 W 12th Ave, Columbus, OH, 43210, USA.

Cancer Letters
|February 10, 2025
PubMed

Insights

Protein canopy homolog 2 (CNPY2) regulates Toll-like receptor 4 (TLR4) in macrophages, impacting inflammation and liver cancer development. CNPY2 deficiency reduces tumor growth by inhibiting macrophage infiltration and cytokine production.

Area of Science:

  • Immunology
  • Oncology
  • Molecular Biology

Background:

  • Tumor-associated macrophages (TAMs) are key in the tumor microenvironment.
  • The specific roles of TAMs in inflammation-driven cancer are not fully understood.

Purpose of the Study:

  • To investigate the function of protein canopy homolog 2 (CNPY2) in macrophage regulation.
  • To elucidate the mechanisms by which CNPY2 influences inflammation-associated oncogenesis, particularly in liver cancer.

Main Methods:

  • Investigated CNPY2's interaction with Toll-like receptor 4 (TLR4) in macrophages.
  • Utilized macrophage-specific CNPY2 deficiency models and a diethylnitrosamine (DEN)-induced liver cancer model.
  • Performed RNA-sequencing to analyze gene expression changes in Cnpy2 knockout macrophages.

Main Results:

  • CNPY2 directly binds to TLR4, promoting cytokine production in macrophages.
  • CNPY2 deficiency reduces TLR4 expression, NFκB translocation, and macrophage cytokine production.
  • Macrophage-specific CNPY2 deficiency inhibited hepatocarcinogenesis and reduced macrophage infiltration by downregulating VEGF receptors (Flt1, Kdr) via NFκB2/p52 signaling.

Conclusions:

  • CNPY2 is a novel regulator of macrophages involved in both inflammation and hepatocarcinogenesis.
  • CNPY2's role in regulating TLR4 and VEGF receptor expression highlights its potential as a therapeutic target in cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K